ALBUMIN (HUMAN) 25% SOLUTION Canada - anglais - Health Canada

albumin (human) 25% solution

baxter ag - albumin (human) - solution - 25% - albumin (human) 25% - blood derivatives

CSL NEW ZEALAND ALBUMEX 20 human albumin 200g/L injection solution vial Australie - anglais - Department of Health (Therapeutic Goods Administration)

csl new zealand albumex 20 human albumin 200g/l injection solution vial

csl behring australia pty ltd - albumin, quantity: 200 g/l - injection, solution - excipient ingredients: octanoate; sodium - storage conditions: protect from light 1. hypoproteinaemia in acutely ill patients: (a) to increase oncotic pressure (b) as an adjunct to diuretic therapy (c) as a nutrient in paediatrics. 2. resuscitation. in shock due to acute blood or plasma loss together with crystalloid solutions. 3. burns. to maintain colloid osmotic pressure. 4. adult respiratory distress syndrome - used with diuretics. 5. haemodialysis - assists in the rapid removal of excess extravascular fluid and maintain perfusion pressure. 6. therapeutic plasma exchange -used when a patient's serum albumin level is not maintained.

Human Albumin Baxalta 50 g/l inf. sol. i.v. vial Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

human albumin baxalta 50 g/l inf. sol. i.v. vial

baxalta innovations gmbh - albumin human 50 g/l - solution for infusion - 50 g/l - albumin human 50 mg/ml - albumin

ALBUMINA HUMANA 20% BIOTEST SOLUCION PARA INFUSION I.V. Panama - anglais - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

albumina humana 20% biotest solucion para infusion i.v.

biotest pharma gmbh - albÚmina humana - albÚmina humana....20 %

ALBUMINA HUMANA GRIFOLS AL 20% SOLUCION INYECTABLE I.V Panama - anglais - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

albumina humana grifols al 20% solucion inyectable i.v

instituto grifols, s.a. - albÚmina humana - albÚmina humana.... 0.2 g

Human Albumin CSL Behring 200 g/l inf. sol. i.v. vial Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

human albumin csl behring 200 g/l inf. sol. i.v. vial

csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin

Human Albumin CSL Behring 200 g/l inf. sol. i.v. vial Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

human albumin csl behring 200 g/l inf. sol. i.v. vial

csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin

ALBUMINATIV 40MG/ML Israël - anglais - Ministry of Health

albuminativ 40mg/ml

medigal ltd - albumin human 40 mg/ml - solution for injection - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demontrated and use of a colloid such as albumin is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient based on official recommendations.

ALBUMINATIV 200MG/ML Israël - anglais - Ministry of Health

albuminativ 200mg/ml

medigal ltd - albumin human 200 mg/ml - solution for injection - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demontrated, and use of a colloid, such as albumin, is appropriate.the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

ALBUREX 20 AU Human Albumin 200 g/L (20% w/v) 100 mL solution for intravenous infusion vial Australie - anglais - Department of Health (Therapeutic Goods Administration)

alburex 20 au human albumin 200 g/l (20% w/v) 100 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 20 g - injection, intravenous infusion - excipient ingredients: sodium octanoate; water for injections; sodium chloride; sodium acetyltryptophanate - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.